These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19447357)

  • 1. Epistatic interaction between COMT and DAT1 genes on eating behavior: a pilot study.
    Hersrud SL; Stoltenberg SF
    Eat Behav; 2009 Apr; 10(2):131-3. PubMed ID: 19447357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of COMT Val158Met and DAT1 3'-UTR VNTR in illicit drug use and drug-related psychiatric disorders.
    Chen CK; Lin SK; Chiang SC; Su LW; Wang LJ
    Subst Use Misuse; 2014 Sep; 49(11):1385-91. PubMed ID: 24708432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): relationships to eating- and personality-related psychopathology.
    Thaler L; Groleau P; Badawi G; Sycz L; Zeramdini N; Too A; Israel M; Joober R; Bruce KR; Steiger H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):120-8. PubMed ID: 22683321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults.
    Valomon A; Holst SC; Bachmann V; Viola AU; Schmidt C; Zürcher J; Berger W; Cajochen C; Landolt HP
    Chronobiol Int; 2014 Jun; 31(5):705-14. PubMed ID: 24625311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia.
    Prata DP; Mechelli A; Fu CH; Picchioni M; Toulopoulou T; Bramon E; Walshe M; Murray RM; Collier DA; McGuire P
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13600-5. PubMed ID: 19666577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of functional dopaminergic gene polymorphisms in the etiology of idiopathic intellectual disability.
    Bhowmik AD; Chaudhury S; Dutta S; Shaw J; Chatterjee A; Choudhury A; Saha A; Sadhukhan D; Kar T; Sinha S; Mukhopadhyay K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1714-22. PubMed ID: 21609749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis effects of dopamine genes on interval timing and reward magnitude in humans.
    Balcı F; Wiener M; Cavdaroğlu B; Branch Coslett H
    Neuropsychologia; 2013 Jan; 51(2):293-308. PubMed ID: 22903038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic Modulation of Cognitive Preparation for Overt Reading: Evidence from the Study of Genetic Polymorphisms.
    Arnold C; Gispert S; Bonig H; von Wegner F; Somasundaram S; Kell CA
    Cereb Cortex; 2016 Apr; 26(4):1539-1557. PubMed ID: 25596589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females.
    Heitland I; Kenemans JL; Oosting RS; Baas JM; Böcker KB
    Behav Brain Res; 2013 Jul; 249():55-64. PubMed ID: 23619133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine inactivation efficacy related to functional DAT1 and COMT variants influences motor response evaluation.
    Bender S; Rellum T; Freitag C; Resch F; Rietschel M; Treutlein J; Jennen-Steinmetz C; Brandeis D; Banaschewski T; Laucht M
    PLoS One; 2012; 7(5):e37814. PubMed ID: 22649558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
    Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-system genes, childhood abuse, and clinical manifestations in women with Bulimia-Spectrum Disorders.
    Groleau P; Steiger H; Joober R; Bruce KR; Israel M; Badawi G; Zeramdini N; Sycz L
    J Psychiatr Res; 2012 Sep; 46(9):1139-45. PubMed ID: 22733030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two dopamine-modulating genes (DAT1 9/10 and COMT Val/Met) on n-back working memory performance in healthy volunteers.
    Blanchard MM; Chamberlain SR; Roiser J; Robbins TW; Müller U
    Psychol Med; 2011 Mar; 41(3):611-8. PubMed ID: 21272388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in dopamine genes influences responsivity of the human reward system.
    Dreher JC; Kohn P; Kolachana B; Weinberger DR; Berman KF
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):617-22. PubMed ID: 19104049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes of the dopaminergic system selectively modulate top-down but not bottom-up attention.
    Schneider KK; Schote AB; Meyer J; Frings C
    Cogn Affect Behav Neurosci; 2015 Mar; 15(1):104-16. PubMed ID: 25253063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistatic interactions involving DRD2, DRD4, and COMT polymorphisms and risk of substance abuse in women with binge-purge eating disturbances.
    Steiger H; Thaler L; Gauvin L; Joober R; Labbe A; Israel M; Kucer A
    J Psychiatr Res; 2016 Jun; 77():8-14. PubMed ID: 26950642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of DAT1 and COMT variants on neural activation during response inhibition in adolescents with attention-deficit/hyperactivity disorder and healthy controls.
    van Rooij D; Hoekstra PJ; Bralten J; Hakobjan M; Oosterlaan J; Franke B; Rommelse N; Buitelaar JK; Hartman CA
    Psychol Med; 2015 Nov; 45(15):3159-70. PubMed ID: 26073896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
    Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
    Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
    Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
    Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder.
    Heidinger BA; Cameron JD; Vaillancourt R; De Lisio M; Ngu M; Tasca GA; Chyurlia L; Doucet É; Doucette S; Maria Obregón Rivas A; Goldfield GS
    Gene; 2021 May; 781():145538. PubMed ID: 33631245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.